全文获取类型
收费全文 | 33714篇 |
免费 | 2937篇 |
国内免费 | 1151篇 |
专业分类
耳鼻咽喉 | 179篇 |
儿科学 | 754篇 |
妇产科学 | 351篇 |
基础医学 | 9880篇 |
口腔科学 | 518篇 |
临床医学 | 2799篇 |
内科学 | 5714篇 |
皮肤病学 | 1013篇 |
神经病学 | 1133篇 |
特种医学 | 563篇 |
外国民族医学 | 12篇 |
外科学 | 2464篇 |
综合类 | 4371篇 |
现状与发展 | 7篇 |
预防医学 | 1244篇 |
眼科学 | 250篇 |
药学 | 2344篇 |
2篇 | |
中国医学 | 672篇 |
肿瘤学 | 3532篇 |
出版年
2024年 | 48篇 |
2023年 | 343篇 |
2022年 | 650篇 |
2021年 | 906篇 |
2020年 | 833篇 |
2019年 | 926篇 |
2018年 | 885篇 |
2017年 | 913篇 |
2016年 | 1002篇 |
2015年 | 1263篇 |
2014年 | 1782篇 |
2013年 | 2128篇 |
2012年 | 1771篇 |
2011年 | 2421篇 |
2010年 | 2044篇 |
2009年 | 2248篇 |
2008年 | 1982篇 |
2007年 | 1976篇 |
2006年 | 1885篇 |
2005年 | 1648篇 |
2004年 | 1517篇 |
2003年 | 1382篇 |
2002年 | 1115篇 |
2001年 | 898篇 |
2000年 | 765篇 |
1999年 | 654篇 |
1998年 | 638篇 |
1997年 | 494篇 |
1996年 | 490篇 |
1995年 | 486篇 |
1994年 | 370篇 |
1993年 | 303篇 |
1992年 | 162篇 |
1991年 | 162篇 |
1990年 | 97篇 |
1989年 | 58篇 |
1988年 | 51篇 |
1987年 | 32篇 |
1986年 | 23篇 |
1985年 | 57篇 |
1984年 | 67篇 |
1983年 | 58篇 |
1982年 | 40篇 |
1981年 | 44篇 |
1980年 | 33篇 |
1979年 | 37篇 |
1978年 | 25篇 |
1977年 | 26篇 |
1975年 | 17篇 |
1973年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
91.
Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis 总被引:4,自引:0,他引:4
Summary Levels of soluble IL-2 receptors, IL-6, soluble CD23, soluble CD14 and ECP (eosinophilic cationic protein) were measured as markers of T-cell, B-cell, monocyte and eosinophilic leucocyte activation in 26 patients with atopic dermatitis (AD) on admission to (A) and at discharge from (D) the Department of Dermatology in Zurich. The serum levels of sIL-2R, IL-6, sCD23, sCD14 and ECP were significantly elevated in AD patients in comparison with the normal values of healthy donors. A significant decrease in sIL-2R (p=0.0093) and in sCD14 (p=0.0134) levels was demonstrated between A and D, correlating with the improvement in the skin intensity score (SIS). In addition, a significant correlation of the sCD14 levels and the SIS at A was demonstrated (p=0.0415). These results also incriminate monocytes in the pathogenesis of AD, indicating that, besides sIL-2R and ECP, SCD14 could also be a possible marker for the disease activity. 相似文献
92.
P. KORKOLOPOULOU J. CORDELL M. JONES L. KAKLAMANIS A. TSENGA K.C. GATTER D.Y. MASON 《Histopathology》1994,24(6):511-515
Recent evidence indicates that membrane-bound immunoglobulin on B lymphocytes is associated with a molecule which comprises the products of the mb-1 and B29 genes. This molecule is a highly specific marker for B-cells, presumably because of its central functional role in antigen triggering, and has recently been clustered as CD79a at the 5th Leucocyte Workshop. Recently there has been controversy surrounding reports of B-cell antigen expression by Reed–Sternberg and related cells, and we have therefore studied 108 cases of Hodgkin's disease immunohistochemically using a novel antibody which detects mb-1 protein in paraffin sections. The results were compared with those achieved using antibody L26 to detect CD20. The mb-1 protein was present in the neoplastic cells in all 14 cases of lymphocyte predominance Hodgkin's disease studied, and CD20 immunoreactivity was also found in seven of the eight cases of this subtype studied. Of the non-lymphocyte predominance cases, 20% (19/94) expressed mb-1 and 30% (20/67) CD20 in the Reed–Sternberg cells, but the cells positive for either of these two markers usually constituted only a very small proportion of the neoplastic population. However, in occasional cases (one of 94 for mb-1 and five of 67 for CD20), more than 50% of the neoplastic cells expressed one or both B-cell antigens. These results confirm the B-cell origin of the neoplastic cells in lymphocyte predominance Hodgkin's disease, but they also indicate that, contrary to our previous study, mb-1 expression may occasionally be found in what appears, on histological grounds, to be other types of Hodgkin's disease. 相似文献
93.
94.
Corinna S. Bowser Jean Kaye Rauno O. Joks Cascy-Arnoux Charlot H. Jack Moallem 《Pediatric allergy and immunology》2007,18(4):298-303
Elevated serum immunoglobulin E (IgE) and increased prevalence of atopy is reported in patients infected with human immunodeficiency virus (HIV). The elevated serum IgE may be attributed to polyclonal stimulation of B cells or IgE production against allergens, viruses, fungi and bacteria. This study investigates the prevalence of atopy in perinatally HIV-infected children, and the relationships between serum IgE (and other serum immunoglobulins) with atopy, CD4+ cell count and HIV-disease stage. Serum immunoglobulin levels, epicutaneous skin test for common aeroallergens, clinical Centers for Disease Control and Prevention (CDC) classification, CD4+ cell counts and allergy history were extracted from the charts of perinatally HIV-infected children on highly active antiretroviral therapy. The prevalence of atopy (52%) and the pattern of aeroallergen sensitivity were comparable with the US pediatric population. Serum IgE levels did not correlate with clinical disease stage. However, in non-atopic patients, serum IgE levels increased with disease progression (p = 0.02). There was an inverse relationship between the prevalence of elevated serum IgE levels and atopy with progression of disease (p = 0.019). Serum IgE did not correlate with atopy, CD4+ cell count, or duration of HIV infection or levels of serum immunoglobulins. This is the first study to show no increased prevalence of atopy in perinatally HIV-infected children compared with the general population. In advanced stages of HIV, elevated serum IgE may be specific for antigens other than those known as allergens. 相似文献
95.
BACKGROUND: Reduced Th1 and elevated Th2 cytokine responses are considered to be a principal mechanism in the generation of the inflammation leading to the manifestations of atopic disease in the skin of atopic dermatitis and in the airways of asthma. If reduced Th1 and elevated Th2 responses are principal determinants of the manifestation of atopic disease it might be expected that subjects with established disease would exhibit differences in their cytokine profiles as compared with atopic patients without clinical disease. OBJECTIVE: To determine whether asymptomatic atopic children exhibit a cytokine imbalance similar to that seen in patients with established atopic disease or if they behave like non-atopic controls. Cytokine responses in a group of children with elevated IgE but no clinical manifestations of disease, atopic children with established disease and non-atopic controls were compared. METHODS: We examined allergen-induced (house dust mite, HDM, rye grass pollen and RYE) cytokine responses in parallel with polyclonal (staphylococcal enterotoxin B, SEB) cytokine responses in a group of children with elevated serum IgE levels without current or past evidence of atopic disease (median age 6.6 years) and compared these with a non-atopic control group (median age 6.5 years) and a group of children with atopic disease (median age 6.7 years). RESULTS: Symptomatic atopic children had reduced SEB-induced IFN-gamma and increased SEB-induced IL-4 and IL-5 as compared with non-atopic controls. In contrast, SEB-induced IFN-gamma, IL-4 and IL-5 production in asymptomatic atopics was not significantly different from the non-atopic control subjects. Allergen-induced Th1 (IFN-gamma) and Th2 (IL-5 and IL-13) cytokine production was increased in both symptomatic atopics and asymptomatic atopics when compared with non-atopic controls. CONCLUSION: The defect in polyclonally induced IFN-gamma production was associated with the clinical manifestation of atopic disease but not the atopic stateper se. This suggests that the global reduction in IFN-gamma is the key determinant of the development of overt atopic disease. In contrast, elevated allergen-induced Th2 cytokine responses in children related to the atopic state per se irrespective of the presence of clinical atopic disease. 相似文献
96.
白细胞介素-13功能研究进展 总被引:5,自引:0,他引:5
白细胞介素-13主要由活化的Th2(CD4^ )细胞分泌,诱导单核巨噬细胞分化及延长寿命;促进MHC-Ⅱ,CD23表达;抑制炎性和趋化因子产生;诱导B细胞增殖,活化,刺激IgM,IgG的产生和重链的转换;使血管细胞粘附分子-1表达;抑制人类免疫缺陷病毒(HIV)复制;间接诱导巨噬细胞和NK细胞参与抗肿瘤作用。在变态反应性疾病和哮喘中引起呼吸道高反应性,嗜酸粒细胞性炎症,粘液分泌过多,基膜纤维化等,其受体是与IL-4Rα形成功能复合体而发挥作用。IL-13信号转导途径除了JAK/STAT6以外,尚有IRS-1,Fes,磷酸激酶,BCL-6/SOCS等途径。 相似文献
97.
M. STEWARD R. BISHOP N.H. PIGGOTT I.D. MILTON B. ANGUS C.H.W. HORNE 《Histopathology》1997,30(1):16-22
Phenotypic analysis of lymphoproliferative disorders is now considered mandatory for accurate classification which is the basis for optimum patient management. This is presently carried out in most cases using a range of antibodies recognizing B and T-cell antigens effective in paraffin sections, and an antibody to CD3 is currently a key member of such panels, indicating T-cell phenotype. Current antibodies to CD3 are polyclonal with the inherent disadvantages of this type of reagent compared to monoclonal antibodies. In this study, we have used a recombinant fusion protein representing part of the epsilon subunit of the CD3 molecule to generate a novel monoclonal antibody (NCL-CD3-PS1) effective in paraffin sections. The antibody has been characterized biochemically and by immunohistochemistry using a wide range of normal and pathological tissues. Lineage and phenotype specificity have been supported in our study and results from other laboratories are awaited with interest. 相似文献
98.
The amyloid precursor protein (APP) gives rise to beta-amyloid peptides, which are the main constituents of senile plaques in brains of Alzheimer's disease (AD) patients. The generation of beta-amyloid peptides requires the enzymatic activity of the beta-site APP-cleaving enzyme 1 (BACE1). BACE1 is primarily expressed by neurons and increased BACE1 protein concentrations and enzymatic activities have been reported in the brains of AD patients. However, there is accumulating evidence that, in addition to neurons, reactive astrocytes are capable of expressing BACE1 and, therefore, may contribute to beta-amyloid plaque formation. This suggests that conditions accompanied by chronic astrocyte activation may contribute to developing AD. Non-amyloidogenic processing of the APP can be stimulated by phorbol esters (PEs) and by intracellular diacylglycerol (DAG) generation. This led to the hypothesis that classical and novel protein kinase Cs (PKCs), which are activated by DAG/PEs, regulate APP processing. However, in addition to PKCs, there are other DAG/PE receptors present in neurons which may participate in the modulation of APP processing. Munc13-1, a presynaptic protein with an essential role in synaptic vesicle priming, represents such an alternative target of the DAG second messenger pathway. Using Munc13-1 knock-out mice and human neuroblastoma cells transfected with wild-type and mutant Munc13-1 constructs it was demonstrated that Munc13-1 acts independently of and in parallel with PKC to modulate APP metabolism. Therefore, agonists specific for the Munc13-1 C1-domain or small molecules mimicking the function of the endogenous Munc13-1 activator RIM1 may prove useful to shift APP processing towards the non-amyloidogenic pathway. 相似文献
99.
目的:以原位杂交法检测PPL13在人胎盘组织的表达情况。方法:用DIG标记的PPL13有义RNA探针及反义RNA探针与胎盘组织切片进行原位杂交。结果:反义RNA探针杂交标本显色3h,显微镜下可见胎盘毛细血管内皮细胞中出现棕色沉淀物,滋养层细胞中未见棕色沉淀物;而有义RNA探针杂交标本显色24h仍无棕色沉淀物出现。结论:PPL13在人胎盘内皮细胞中特异性表达.提示PPL13可能与胎盘的屏障作用有关。 相似文献
100.